Over half a million women die each year from pregnancy related causes, 99% in low and
middle income countries. In many low income countries, complications of pregnancy and …

Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …

Background Pre-eclampsia is a major cause of mortality and morbidity during pregnancy
and childbirth. Antiplatelet agents, especially low-dose aspirin, might prevent or delay pre …

This resource summarizes the most authoritative evidence available on the effects of care
practices carried out during pregnancy, childbirth, and immediately after birth, and in …

Background Antihypertensive drugs are often used in the belief that lowering blood pressure
will prevent progression to more severe disease, and thereby improve pregnancy outcome …

Background Infants born preterm (before 37 weeks' gestation) have poorer outcomes than
infants at term, particularly if born before 32 weeks. Early cord clamping has been standard …

Magnesium sulphate and other anticonvulsants for women with pre‐eclampsia - Duley, L - 2010
| Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Objective To present estimates of maternal mortality associated with hypertensive disorders
of pregnancy in Africa, Asia, Latin America and the Caribbean, and to discuss strategies to …

Background Very high blood pressure during pregnancy poses a serious threat to women
and their babies. The aim of antihypertensive therapy is to lower blood pressure quickly but …

Background The number of visits for antenatal (prenatal) care developed without evidence
of how many visits are necessary. The content of each visit also needs evaluation …